Literature DB >> 9054475

Lactic acidosis and other mitochondrial disorders.

P W Stacpoole1.   

Abstract

The ability of mitochondria to oxidize substrates and generate energy is integral to normal homeostasis and to the ability of cells to survive in the face of impending energy failure. Lactic acidosis is a common and readily apparent biochemical marker for mitochondrial dysfunction. However, lactic acidosis represents only the most obvious example in which acquired or congenital abnormalities of mitochondrial oxidative phosphorylating capacity contribute to the pathobiology and phenotypic expression of a broad spectrum of clinical disorders. Consequently, interventions that improve mitochondrial function or prevent mitochondrial energy failure may have widespread therapeutic implications.

Entities:  

Mesh:

Year:  1997        PMID: 9054475     DOI: 10.1016/s0026-0495(97)90259-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Unusual presentation of anaplastic large cell lymphoma with clinical course mimicking fever of unknown origin and sepsis: autopsy study of five cases.

Authors:  Marina B Mosunjac; J Bruce Sundstrom; Mario I Mosunjac
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

2.  Treatment of congenital lactic acidosis with dichloroacetate.

Authors:  P W Stacpoole; C L Barnes; M D Hurbanis; S L Cannon; D S Kerr
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 3.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

Review 4.  Mitochondrial toxicity and HIV therapy.

Authors:  A J White
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

5.  Mitochondrial Toxicity Associated with Nucleoside Reverse Transcriptase Inhibitor Therapy.

Authors:  Cecilia M. Shikuma; Bruce Shiramizu
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

6.  Complete Mitochondrial Complex I Deficiency Induces an Up-Regulation of Respiratory Fluxes That Is Abolished by Traces of Functional Complex I.

Authors:  Kristina Kühn; Toshihiro Obata; Kristen Feher; Ralph Bock; Alisdair R Fernie; Etienne H Meyer
Journal:  Plant Physiol       Date:  2015-07-01       Impact factor: 8.340

7.  Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation.

Authors:  Lokendra Kumar Sharma; Hezhi Fang; Jiangtao Liu; Rasika Vartak; Janice Deng; Yidong Bai
Journal:  Hum Mol Genet       Date:  2011-09-02       Impact factor: 6.150

Review 8.  Sleep disorders associated with primary mitochondrial diseases.

Authors:  Ryan J Ramezani; Peter W Stacpoole
Journal:  J Clin Sleep Med       Date:  2014-11-15       Impact factor: 4.062

Review 9.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

10.  A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.

Authors:  Jeong Soon Park; Lokendra Kumar Sharma; Hongzhi Li; Ruihua Xiang; Deborah Holstein; Jun Wu; James Lechleiter; Susan L Naylor; Janice J Deng; Jianxin Lu; Yidong Bai
Journal:  Hum Mol Genet       Date:  2009-02-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.